ACIU

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

AC Immune Ltd

NASDAQ | ACIU

2.46

USD

$0.00

(

0.00%

)

At Close (As of Sep 17, 2025)

$255.52M

Market Cap

-

P/E Ratio

-0.63

EPS

$3.98

52 Week High

$1.43

52 Week Low

HEALTHCARE

Sector

ACIU Chart

Recent Chart
Price Action

ACIU Technicals

Tags:

ACIU Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (CHF)
Gross Profit $27M
Total Revenue $27M
Cost Of Revenue $63M
Costof Goods And Services Sold $63M
Operating Income -$52M
Selling General And Administrative $11M
Research And Development $63M
Operating Expenses $80M
Investment Income Net -
Net Interest Income $3.1M
Interest Income $3.2M
Interest Expense $133K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.2M
Income Before Tax -$51M
Income Tax Expense $3K
Interest And Debt Expense -
Net Income From Continuing Operations -$51M
Comprehensive Income Net Of Tax -
Ebit -$51M
Ebitda -$49M
Net Income -$51M

Revenue & Profitability

Earnings Performance

ACIU Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (CHF)
Total Assets $231M
Total Current Assets $172M
Cash And Cash Equivalents At Carrying Value $36M
Cash And Short Term Investments $36M
Inventory -
Current Net Receivables $2.2M
Total Non Current Assets $59M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $50M
Intangible Assets Excluding Goodwill $50M
Goodwill -
Investments -
Long Term Investments $415K
Short Term Investments $129M
Other Current Assets $4.3M
Other Non Current Assets -
Total Liabilities $119M
Total Current Liabilities $101M
Current Accounts Payable $2.7M
Deferred Revenue -
Current Debt -
Short Term Debt $1M
Total Non Current Liabilities $18M
Capital Lease Obligations $5.4M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $5.4M
Other Current Liabilities $12M
Other Non Current Liabilities -
Total Shareholder Equity $112M
Treasury Stock -
Retained Earnings -$368M
Common Stock $2.2M
Common Stock Shares Outstanding $100M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (CHF)
Operating Cashflow $66M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2.2M
Capital Expenditures $576K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$105M
Cashflow From Financing -$1.1M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$51M

yearly Income Statement (As of Dec 31, 2024)

Field Value (CHF)
Gross Profit $27M
Total Revenue $27M
Cost Of Revenue $63M
Costof Goods And Services Sold $63M
Operating Income -$52M
Selling General And Administrative $11M
Research And Development $63M
Operating Expenses $80M
Investment Income Net -
Net Interest Income $3.1M
Interest Income $3.2M
Interest Expense $133K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2.2M
Income Before Tax -$51M
Income Tax Expense $3K
Interest And Debt Expense -
Net Income From Continuing Operations -$51M
Comprehensive Income Net Of Tax -
Ebit -$51M
Ebitda -$49M
Net Income -$51M

ACIU News

ACIU Profile

AC Immune Ltd Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

AC Immune Ltd (Ticker: ACIU) is a leading clinical-stage biopharmaceutical firm headquartered in Lausanne, Switzerland, focused on pioneering therapies and diagnostics for neurodegenerative diseases linked to protein misfolding, including Alzheimer's disease. Leveraging its proprietary platforms, the company is actively engaged in the discovery and development of innovative treatments aimed at modifying disease progression and enhancing patients' quality of life. With a robust pipeline of candidates, AC Immune is positioned at the forefront of addressing some of the most pressing challenges in neurology, making it a compelling prospect for institutional investors seeking exposure to the biopharmaceutical sector.

ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
QBTS
+18.75%
$22.54
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
TSLA
+1.00%
$425.86
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NEHC
-4.00%
$0.45
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
RGTI
+9.94%
$21.99
SOFI
-1.02%
$27.14
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
INTC
-1.46%
$24.90
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
RIOT
+0.57%
$17.62
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
AIRE
-1.57%
$1.25
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
ABEV
0.00%
$2.36
LDI
+2.70%
$4.55
BINI
-6.96%
$0.06
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
QUBT
+4.97%
$17.71
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
CWD
+19.05%
$7.56
JD
+1.52%
$35.24
GPUS
+6.65%
$0.41
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
BTE
-2.49%
$2.54
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
GDXD
+1.63%
$1.24
RXRX
-2.68%
$4.71
RAYA
-4.69%
$0.04
HIMS
-1.06%
$50.35
ATCH
+87.36%
$1.62
NVDA
-2.62%
$170.29
PLUG
+19.04%
$2.00
CGBS
-39.47%
$0.03
CDT
+40.10%
$0.89
BITF
+5.53%
$3.05
SNAP
+3.23%
$7.99
NFE
+8.00%
$2.16
QBTS
+18.75%
$22.54
NIO
+6.12%
$7.45
SPRC
+142.93%
$4.47
GRAB
-3.48%
$6.10
AAL
+0.56%
$12.48
TSLA
+1.00%
$425.86
LYFT
+13.12%
$22.84
GV
+68.16%
$2.80
NEHC
-4.00%
$0.45
NUAI
-4.00%
$0.45
MARA
-1.08%
$17.34
SOUN
+3.25%
$15.16
RGTI
+9.94%
$21.99
SOFI
-1.02%
$27.14
TPIC
-45.91%
$0.12
ADAP
-1.22%
$0.08
PLTR
-1.13%
$168.33
DNN
+1.60%
$2.54
AXDX
-61.36%
$0.03
BBD
+3.11%
$3.31
BMNR
+2.03%
$57.07
INTC
-1.46%
$24.90
PGRE
-11.43%
$6.54
F
+0.52%
$11.67
TNMG
-0.27%
$0.32
IPM
+22.79%
$2.37
LYT
-16.77%
$0.09
BTG
+0.23%
$4.33
JOBY
-1.59%
$14.16
MULN
-12.58%
$0.06
KDLY
-4.66%
$1.43
NAKA
-4.66%
$1.43
WBD
-1.42%
$17.98
RR
+2.84%
$3.98
IONQ
+5.10%
$65.44
RIVN
-1.46%
$14.11
AAPL
+0.35%
$238.99
PFE
+0.62%
$24.05
AVGO
-3.84%
$346.17
UBER
-4.98%
$92.95
RIOT
+0.57%
$17.62
AMZN
-1.03%
$231.62
ACHR
-1.20%
$9.00
AIRE
-1.57%
$1.25
ONDS
+0.16%
$6.10
QS
+1.08%
$10.26
ABEV
0.00%
$2.36
LDI
+2.70%
$4.55
BINI
-6.96%
$0.06
RMBL
+60.50%
$3.21
WULF
+3.74%
$11.35
OPI
-31.80%
$0.56
BAC
+1.46%
$51.40
ADD
-25.47%
$0.05
RELI
+6.58%
$0.72
TLRY
-2.45%
$1.19
AMD
-0.60%
$159.49
ETHD
-1.52%
$3.22
SRM
+53.27%
$10.30
VALE
-0.27%
$10.88
HOOD
+1.07%
$118.64
DVLT
-22.98%
$0.34
NOK
+1.84%
$4.69
QUBT
+4.97%
$17.71
CIFR
+7.55%
$12.38
GOOGL
-0.64%
$249.53
IREN
+3.97%
$37.90
ATYR
-5.09%
$1.02
INFY
+3.63%
$17.68
CWD
+19.05%
$7.56
JD
+1.52%
$35.24
GPUS
+6.65%
$0.41
FAAS
-6.04%
$0.09
ITUB
+1.82%
$7.27
RZLV
-3.60%
$7.08
RIG
-1.87%
$3.40
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BABA
+2.44%
$166.17
KEY
+0.42%
$18.71
BTE
-2.49%
$2.54
NVTS
+9.67%
$6.46
IONZ
-10.28%
$4.80
WLGS
-5.57%
$0.04
CLSK
+2.14%
$11.44
BURU
-0.86%
$0.13
HBAN
+0.63%
$17.54
JBLU
0.00%
$5.07
GDXD
+1.63%
$1.24
RXRX
-2.68%
$4.71
RAYA
-4.69%
$0.04
HIMS
-1.06%
$50.35
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.